Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

15 mai 2026 07h39 HE | Source: Research and Markets

Tetraspecific Antibodies Clinical Pipeline Market research 2026: Development Technologies, Therapeutic Approaches & Market Opportunity Insight to 2032

Dublin, May 15, 2026 (GLOBE NEWSWIRE) -- The "Tetraspecific Antibodies Clinical Pipeline, Development Technologies, Therapeutic Approaches & Market Opportunity Insight 2026" report has been...
15 mai 2026 05h22 HE | Source: Research and Markets

Benlysta Sales Forecast and Market Size Analysis Report 2026-2034 with Focus on United States, Germany, France, Italy, Spain, United Kingdom, and Japan

Dublin, May 15, 2026 (GLOBE NEWSWIRE) -- The "Benlysta Sales Forecast and Market Size Analysis - 2034" has been added to ResearchAndMarkets.com's offering. The report offers insights into...
14 mai 2026 09h43 HE | Source: Research and Markets

Complement C5 Inhibitors & C5 Receptor Antagonists Pipeline Competitor Analysis Report 2026: Active R&D Programs by R&D Phase and Profile of Targeted Immunotherapies by Drug Modality

Dublin, May 14, 2026 (GLOBE NEWSWIRE) -- The "Pipeline of Complement C5 Inhibitors & C5 Receptor Antagonists" report has been added to ResearchAndMarkets.com's offering.This competitive...
14 mai 2026 09h39 HE | Source: Research and Markets

PD-L1 X 4-1BB (CD137) Bispecific Antibodies Pipeline Competitor Analysis Report 2026: Active R&D Programs by R&D Phase and Profile of Bispecific Antibodies by Drug Modality

Dublin, May 14, 2026 (GLOBE NEWSWIRE) -- The "Pipeline of PD-L1 x 4-1BB (CD137) Bispecific Antibodies" report has been added to ResearchAndMarkets.com's offering.This competitive intelligence...
14 mai 2026 09h25 HE | Source: Research and Markets

Interleukin-6 (IL-6) Receptor Antagonists and IL6- Inhibitors Pipeline Competitor Analysis Report 2026: Active R&D Programs by R&D Phase and Profile of Antagonists and Inhibitors by Drug Modality

Dublin, May 14, 2026 (GLOBE NEWSWIRE) -- The "Pipeline of Interleukin-6 (IL-6) Receptor Antagonists and IL6- Inhibitors" report has been added to ResearchAndMarkets.com's offering.This competitive...
12 mai 2026 08h40 HE | Source: Fortis Life Sciences

Fortis Life Sciences Awards 2026 AbNano® VHH Discovery Grant to Deliver Biosciences for Targeted Drug Delivery Research

Fortis Life Sciences awards Deliver Biosciences the 2026 AbNano® VHH Discovery Grant for in vivo CAR-T, gene therapy & nanoparticle drug delivery research
08 mai 2026 09h39 HE | Source: Research and Markets

Europe's $154+ Million AI in Antibody Discovery Market, 2025-2035: Precision Therapies and AI Integration Spur Market Transformation

Dublin, May 08, 2026 (GLOBE NEWSWIRE) -- The "Europe AI in Antibody Discovery Market: Analysis and Forecast, 2025-2035" has been added to ResearchAndMarkets.com's offering. The Europe AI in...
07 mai 2026 08h56 HE | Source: Research and Markets

Asia-Pacific AI in Antibody Discovery Research Report 2026: $1.24 Bn Market Analysis and Forecast 2025-2035 - Rapid Adoption of AI Across Emerging Biopharma Hubs

Dublin, May 07, 2026 (GLOBE NEWSWIRE) -- The "Asia-Pacific AI in Antibody Discovery Market: Analysis and Forecast, 2025-2035" report has been added to ResearchAndMarkets.com's offering.The...
28 avr. 2026 04h01 HE | Source: Research and Markets

AI in Antibody Discovery Market Research Report 2025-2035: Surging Demand for Next-Generation Biologics and Leveraging AI for Personalized Precision Medicine in Antibody Discovery Gaining Traction

Dublin, April 28, 2026 (GLOBE NEWSWIRE) -- The "AI in Antibody Discovery Market - A Global and Regional Analysis: Focus on Technology, Solution, Application, End User, and Country, 2025-2035" report...
21 avr. 2026 06h10 HE | Source: Research and Markets

Chronic Granulomatous Disease (CGD) Market Analysis and Outlook Report 2026-2036 - Emerging Gene Therapies, Lentiviral Vector-based Therapies and CRISPR-Cas9 Gene Editing, Ignite Hope

Dublin, April 21, 2026 (GLOBE NEWSWIRE) -- The "Chronic Granulomatous Disease Market: Focus on Treatment Type, Route of Administration, Distribution Channel, Country and Regional Analysis,...

Page suivante